Welcome to the Targeted Radiopharmaceuticals Europe Therapeutics Blog
Click to explore all of our content related to the 2026 event.
Radiopharmaceuticals at a Turning Point
Breakthrough data, billion-dollar deals, supply challenges, and the leaders defining what's next for RLT.
Radioligand Therapy: How RLT is Transforming the Future of Precision Cancer Treatment
From next-generation targets and alpha therapies to isotope supply and regulatory evolution, explore the trends driving radioligand therapy forward and how Europe's leaders are tackling them at the 8th Targeted Radiopharmaceuticals Summit Europe.
Explore the Agenda
Discover the scientific, clinical and commercial strategies that will become your blueprint for accelerating targeted radiopharmaceuticals from discovery to patients.
Partner With Us
Showcase your technologies and services to 200+ senior decision-makers actively seeking CROs, CDMOs, isotope suppliers, radiopharmacies, dosimetry providers and specialist partners to advance the next generation of radiopharmaceuticals.
Join Europe's TRP Leaders:
Be part of Europe's most comprehensive targeted radiopharmaceuticals forum, uniting pharma, biotech, regulators, clinical centres, investors and solution providers to shape the future of radioligand therapy.